Fonte: European Neuropsychopharmacology. Unidade: FM
Assuntos: TERAPIA COMPORTAMENTAL, TERAPIA COGNITIVA, TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), RECEPTORES DE SEROTONINA, ANTIDEPRESSIVOS (USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Q. et al. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder. European Neuropsychopharmacology, v. 23, n. 7, p. 569-580, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2012.06.014. Acesso em: 25 out. 2025.APA
Hoexter, M. Q., Dougherty, D. D., Duran, F. L. S., Lopes, A. C., Diniz, J. B., Batistuzzo, M. C., et al. (2013). Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder. European Neuropsychopharmacology, 23( 7), 569-580. doi:10.1016/j.euroneuro.2012.06.014NLM
Hoexter MQ, Dougherty DD, Duran FLS, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder [Internet]. European Neuropsychopharmacology. 2013 ; 23( 7): 569-580.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.euroneuro.2012.06.014Vancouver
Hoexter MQ, Dougherty DD, Duran FLS, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder [Internet]. European Neuropsychopharmacology. 2013 ; 23( 7): 569-580.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.euroneuro.2012.06.014
